PARP-1 Expression and BRCA1 Mutations in Breast Cancer Patients’ CTCs

SIMPLE SUMMARY: Recent estimates have shown that approx. 70% of individuals with BRCA1 mutations will develop breast cancer by the age of 70. To make matters worse, breast cancer patients with BRCA1 mutations are more likely to have the more aggressive triple-negative breast cancer. PARPs, belong to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sklias, Thodoris, Vardas, Vasileios, Pantazaka, Evangelia, Christopoulou, Athina, Georgoulias, Vassilis, Kotsakis, Athanasios, Vasilopoulos, Yiannis, Kallergi, Galatea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996866/
https://www.ncbi.nlm.nih.gov/pubmed/35406503
http://dx.doi.org/10.3390/cancers14071731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996866/
https://www.ncbi.nlm.nih.gov/pubmed/35406503
http://dx.doi.org/10.3390/cancers14071731

Ejemplares similares